Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia

dc.contributor.author	Ma, H
dc.contributor.author	Zhou, H
dc.contributor.author	Song, X
dc.contributor.author	Shi, S
dc.contributor.author	Zhang, J
dc.contributor.author	Jia, L
dc.date.accessioned	2015-03-04T07:07:05Z
dc.date.available	2015-03-04T07:07:05Z
dc.date.issued	2015
dc.identifier.citation	Oncogene 34(2015) s. 726-740	en_US
dc.identifier.cristinID	FRIDAID 1123755
dc.identifier.doi	10.1038/onc.2014.7
dc.identifier.issn	0950-9232
dc.identifier.uri	https://hdl.handle.net/10037/7299
dc.identifier.urn	URN:NBN:no-uit_munin_6890
dc.language.iso	eng	en_US
dc.publisher	Macmillan Press Ltd.	en_US
dc.rights.accessRights	openAccess
dc.subject	VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762	en_US
dc.subject	VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762	en_US
dc.title	Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia	en_US
dc.type	Journal article	en_US
dc.type	Tidsskriftartikkel	en_US
dc.type	Peer reviewed	en_US